Clinical Trials Logo

Physiology clinical trials

View clinical trials related to Physiology.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05604339 Completed - Physiology Clinical Trials

Study of Recovery and Blood Rheology Changes in Ultra-endurance Runners (ERUPTION-3)

ERUPTION-3
Start date: September 20, 2022
Phase:
Study type: Observational

While the acute consequences of an ultratrail are beginning to be well documented, data on the study of recovery in the aftermath of an event are much rarer. In order to overcome these various limitations, the main study of the ERUPTION-3 project is set up on the Grand Raid de La Réunion 2022 races. In the context of exercise responses, the rheological properties of blood can impact the endurance performance. In contrast to short-distance events, the study of blood rheology and red blood cells integrity in long-distance events such as ultra-endurance races is poorly documented in the literature. In the ancillary study, the work that is intended to be carried y out will complement the initial results found by a previous research on 23 runners during the Ultra Trail du Mont Blanc. This ancillary study will also be an opportunity to complete the data from the main study by studying the kinetics of biomarker recovery.

NCT ID: NCT05362383 Completed - Clinical trials for Orthognathic Surgery

Use of TENS for the Recovery of Oral Function After Orthognathic Surgery

Start date: February 1, 2013
Phase: N/A
Study type: Interventional

Oral functions of patients are markedly diminished immediately after orthognathic surgery, and novel approaches are needed to accelerate their recovery. The aim of this study is to examine the usefulness of weekly applications of transcutaneous electrical nerve stimulation (TENS) for this purpose, based on evidence of its effectiveness in other types of patients with muscle alterations. The main objective is to determine whether weekly TENS applications can increase the bite force and jaw opening in patients undergoing orthognathic surgery and decrease their pain and inflammation

NCT ID: NCT04508270 Completed - Exercise Clinical Trials

Significance of Early Mobilization After VATS-L

Start date: September 8, 2020
Phase:
Study type: Observational

The main endpoint is physiological rehabilitation after VATS-L under early mobilization. The secondary endpoints are exploring the effect of early mobilization on postoperative physiology. Investigators hypothesis that early mobilization is clearly advantaged to advance the physiological recovery.

NCT ID: NCT03916770 Completed - Muscle Spasticity Clinical Trials

The Effect of Whole Body Vibration (WBV) on Spasticity in Poststroke Hemiplegia

WBV
Start date: August 1, 2019
Phase: N/A
Study type: Interventional

The primary purpose of this study is to show whether WBV application has antispastic effect. The secondary aim is to demonstrate whether WBV has neuromodulatory activity on increased stretch reflex and motor neuron activity, which is the basis of the pathophysiology of spasticity.Hypotheses of this study:Whole body vibration in poststroke hemiplegia reduces ankle plantar flexion spasticity. 1. WBV ; reduces plantar flexor spasticity after stroke 2. WBV decreases poststroke spasticity, by decreasing increased stretch reflex and motor neuron activity.

NCT ID: NCT03807258 Completed - Physiology Clinical Trials

Functional Implication of Corpus Callosum in Voluntary Strength in COPD Patients

Start date: October 20, 2018
Phase: N/A
Study type: Interventional

Patients with COPD have lower capability of activating their muscles. At the cortical level, force production is not only controlled by contralateral primary motor cortex but also by ipsilateral motor cortex. The aim of this study is to determine whether ipsilateral areas are functionally impaired in COPD.

NCT ID: NCT03751410 Completed - Echocardiography Clinical Trials

Chronic Ibrutinib Therapy Effect on Left Atrial Function

CITE-LA
Start date: December 1, 2018
Phase:
Study type: Observational [Patient Registry]

Ibrutinib is an irreversible Bruton tyrosine-kinase inhibitor. In prospective studies, the ibrutinib efficacy in the treatment of various B-cell malignancies was established. Different ibrutinib side-effects have been found: diarrhea, arthralgia, infections, neutropenia, hypertension and increased risk of bleeding. Most of the mentioned side-effects were <3rd degree of severity and mostly didn't require dose adjustment or therapy discontinuation. Also, there was an increase in the incidence of atrial fibrillation (AFib) (6-16%). The AFib pathogenesis in this patient population is not clarified, but there are indications that ibrutinib inhibits phosphoinositide-3-kinase (PI3K)-Akt signal-pathway expressed in the myocytes. Regardless of the molecular pathogenesis, the clinical effect of ibrutinib on the myocardium, especially the left atrium, has not been studied. Hence, the aim of this study is to determine the ibrutinib effect on echocardiographic parameters of left atrial function. This study will be performed as a clinical, prospective, observational cohort study with a structured follow-up period of 12 months. All consecutive patients with hemato-oncologic diseases (including chronic lymphocytic leukemia, Mantle-cell lymphoma, Waldenstrom macroglobulinemia, etc.) prescribed with chronic ibrutinib therapy, who are able to understand and sign informed consent, will be enrolled. Primary objective is change of the left atrial function measured by the decrease of the left atrial strain deformation > 10%. Recruiting should not exceed 12 months with the minimal follow-up period of 12 months (24 months in total). Standardized statistical methods and tests will be done using SPSS Version 22.0 or newer. This unique study offers the possibility to show the long-term effect of chronic ibrutinib therapy on left atrial function assessed by transthoracic echocardiography. This observational data is needed to further refine the treatment of these patients and to prevent possible side-effects of ibrutinib which could endanger this specific patient population.

NCT ID: NCT03705936 Completed - Physiology Clinical Trials

Metaplasticity in Human Pharyngeal Motor Cortex

Start date: October 24, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the effects of giving 2 doses of brain stimulation through repetitive transcranial magnetic stimulation (rTMS) on swallowing neurophysiology (brain function) in healthy adults.

NCT ID: NCT03424551 Completed - Physiology Clinical Trials

Vibration Induced Reflex Responses and Estimation of TVR

VIRR&TVR
Start date: January 23, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to estimate tonic vibration latency and whole body vibration reflex latency

NCT ID: NCT03368703 Completed - Physiology Clinical Trials

Physiopathology of Lower Cortical Activation in COPD Patients: Contribution of Cortical Neuromodulation

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

Patients with COPD have lower cortical activation and higher cortical inhibitory levels. The purpose of this study is to test the reversibility the lower cortical activation by counterbalancing the increased cortical inhibitory levels with neuro-modulation.

NCT ID: NCT02850367 Completed - Physiology Clinical Trials

Effect of NO Precursors on Physiological Responses to Exercise

NO-SUP
Start date: May 9, 2016
Phase: N/A
Study type: Interventional

NO is an ubiquitous molecule contributing to many physiological functions such as vasodilation, immune and oxidative stress responses. NO production can be supplemented either by providing substrate to the NO-synthase (L-Arginine and L-Citruline) or by providing nitrate which can lead to NO. In the present project the investigators evaluate the effect of various acute and chronic oral NO precursors supplementation on exercise performance and responses in healthy young and older subjects.